Showing results (271-280 of 318) with videos related to
Sort By:
Pageof 32
International Journal of Radiation Oncology, Biology, Physics|August 1, 1985
Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited diseaseR Arriagada, T Le Chevalier, P Baldeyrou, et al.Physical Chemistry Chemical Physics : PCCP|January 9, 2023
Structural and dynamical insights into SilE silver binding from combined analytical probesYoan Monneau, Cyrielle Arrault, Coraline Duroux, et al.Bulletin Du Cancer|January 1, 1989
Limited small cell lung cancer: possible prognostic impact of initial chemotherapy dosesR Arriagada, H de The, T Le Chevalier, et al.Neurosurgery|July 11, 2023
Impact of the Mean Cochlear Biologically Effective Dose on Hearing Preservation After Stereotactic Radiosurgery for Vestibular Schwannoma: A Retrospective Longitudinal AnalysisConstantin Tuleasca, Iuliana Toma-Dasu, Sebastien Duroux, et al.Vaccines|March 26, 2022
IMGT® Biocuration and Analysis of the Rhesus Monkey IG LociViviane Nguefack Ngoune, Morgane Bertignac, Maria Georga, et al.Presse Medicale (Paris, France : 1983)|May 25, 1985
[Alternating chemotherapy and radiotherapy in the induction treatment of small cell bronchial carcinoma (forms limited to the thorax)]T Le Chevalier, R Arriagada, P Baldeyrou, et al.Medchemcomm|December 19, 2017
Bitopic fluorescent antagonists of the A2A adenosine receptor based on pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine functionalized congenersRomain Duroux, Antonella Ciancetta, Philip Mannes, et al.Biodata Mining|February 20, 2021
Performance of model-based multifactor dimensionality reduction methods for epistasis detection by controlling population structureFentaw Abegaz, François Van Lishout, Jestinah M Mahachie John, et al.Nanoscale|December 3, 2024
Porphyrin J-aggregates as a probe for chiral impurities as demonstrated by their symmetry breaking by confinement in montmorillonite clayMatheus de Souza Lima Mendes, Gautier Duroux, Anthony Boudier, et al.Molecules (Basel, Switzerland)|August 29, 2024
Novel Quinazoline Derivatives as Highly Effective A2A Adenosine Receptor AntagonistsAmélie Laversin, Robin Dufossez, Raphaël Bolteau, et al.Pageof 32